Current Volume 13(1) 2008 Supl. (48) - Page: 2

01 Jan 2008   

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre,

01 Jan 2008   

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

01 Jan 2008   

Generic products – requirements for drug registration

P. K. Kunicki,

01 Jan 2008   

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq,

01 Jan 2008   

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers,

01 Jan 2008   

Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients

T. van Gelde,

01 Jan 2008   

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud,

01 Jan 2008   

Therapeutic drug monitoring of tacrolimus

P. Wallemacq,

01 Jan 2008   

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

01 Jan 2008   

Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine

L. M. Shaw, M. Figurski, [...] M. D. Pescovitz - Show fewer authors

01 Jan 2008   

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet,

01 Jan 2008   

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

01 Jan 2008   

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer,

01 Jan 2008   

Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice

M. Korecka,

01 Jan 2008   

Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs

P. J. Taylor,

01 Jan 2008   

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich,

01 Jan 2008   

PK/PD modelling of immunosuppressive agents

E. Wyska,

01 Jan 2008   

Drug transporters for immunosuppressive agents

I.A.M. MacPhee,

01 Jan 2008   

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink,

01 Jan 2008   

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

01 Jan 2008   

Clinical immunosuppression – current status

M. Klinger,

01 Jan 2008   

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet,

01 Jan 2008   

Organ transplantation in Poland

M. Durlik,

01 Jan 2008 :   

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar, [...] K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger - Show fewer authors

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

410 0

01 Jan 2008 :   

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari,

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

363 0

01 Jan 2008 :   

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde, [...] J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten - Show fewer authors

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

446 0

01 Jan 2008 :   

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, [...] C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi - Show fewer authors

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

410 0

01 Jan 2008 :   

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot, [...] P. Glander, W. Weimar, T. van Gelder - Show fewer authors

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

412 0

01 Jan 2008 :   

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova, [...] Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht - Show fewer authors

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

405 0

01 Jan 2008 :   

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, [...] B. Gutkowska, F. Herold - Show fewer authors

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

374 0

01 Jan 2008 :   

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska, [...] M. Głyda, N. Wachowiak - Show fewer authors

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

372 0

01 Jan 2008 :   

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa, [...] B. Jedlickova, J. Segethova - Show fewer authors

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

378 0

01 Jan 2008 :   

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica, [...] E. Ignacak, J. W. Naskalski - Show fewer authors

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

399 0

01 Jan 2008 :   

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg, [...] A. Fasth, C. E. Staatz - Show fewer authors

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

363 0

01 Jan 2008 :   

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek, [...] M. Boratyńska, K. Falkiewicz, M. Klinger - Show fewer authors

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

511 0

01 Jan 2008 :   

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock, [...] K. Tentschert, A. Griesmacher - Show fewer authors

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

374 0

01 Jan 2008 :   

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel, [...] M. Outeda Macías, I. Martín Herranz - Show fewer authors

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

356 0

01 Jan 2008 :   

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet, [...] H. Ait-Youcef - Show fewer authors

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

419 0

01 Jan 2008 :   

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana, [...] S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring - Show fewer authors

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

420 0

01 Jan 2008 :   

Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology

A. M. Taylor, T. N. Gamble, [...] D. Blake, T. Drury, M. Ehrdhard - Show fewer authors

Ann Transplant 2008; 13(1): 36-37 :: ID: 880195

373 0

01 Jan 2008 :   

High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system

R. Ruzicka, M. Kozak, [...] V. Bodepudi, R. Loor, J. Zonderman - Show fewer authors

Ann Transplant 2008; 13(1): 36-36 :: ID: 880194

392 0

01 Jan 2008 :   

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, [...] C. E. Gonde, M. Pires, J. Tracey, M. Tredger - Show fewer authors

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

440 0

29 Sep 2008 :   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri,

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

388 0

01 Jan 2008 :   

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens, [...] Y. Vanrenterghem, D. R. Kuypers - Show fewer authors

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

396 0

01 Jan 2008 :   

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide, [...] C. Kodzu, Y. Ijiri, K. Tanaka - Show fewer authors

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

391 0

01 Jan 2008 :   

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens, [...] K. Verbeke, Y. Vanrenterghem, D. R. Kuypers - Show fewer authors

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

396 0

01 Jan 2008 :   

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo, [...] F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro - Show fewer authors

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

375 0

01 Jan 2008 :   

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens, [...] Y. Vanrenterghem, D. R. Kuypers - Show fewer authors

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

494 0

01 Jan 2008 :   

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre,

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

399 0

01 Jan 2008 :   

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

359 0

01 Jan 2008 :   

Generic products – requirements for drug registration

P. K. Kunicki,

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

330 0

01 Jan 2008 :   

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq,

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

342 0

01 Jan 2008 :   

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers,

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

362 0

01 Jan 2008 :   

Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients

T. van Gelde,

Ann Transplant 2008; 13(1): 27-27 :: ID: 880181

365 0

01 Jan 2008 :   

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud,

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

339 0

01 Jan 2008 :   

Therapeutic drug monitoring of tacrolimus

P. Wallemacq,

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

351 0

01 Jan 2008 :   

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

390 0

01 Jan 2008 :   

Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine

L. M. Shaw, M. Figurski, [...] M. D. Pescovitz - Show fewer authors

Ann Transplant 2008; 13(1): 23-23 :: ID: 880177

339 0

01 Jan 2008 :   

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet,

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

392 0

01 Jan 2008 :   

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

331 0

01 Jan 2008 :   

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer,

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

406 0

01 Jan 2008 :   

Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice

M. Korecka,

Ann Transplant 2008; 13(1): 19-19 :: ID: 880173

335 0

01 Jan 2008 :   

Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs

P. J. Taylor,

Ann Transplant 2008; 13(1): 18-18 :: ID: 880172

638 0

01 Jan 2008 :   

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich,

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

420 0

01 Jan 2008 :   

PK/PD modelling of immunosuppressive agents

E. Wyska,

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

459 0

01 Jan 2008 :   

Drug transporters for immunosuppressive agents

I.A.M. MacPhee,

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

300 0

01 Jan 2008 :   

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink,

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

468 0

01 Jan 2008 :   

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

456 0

01 Jan 2008 :   

Clinical immunosuppression – current status

M. Klinger,

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

446 0

01 Jan 2008 :   

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet,

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

412 0

01 Jan 2008 :   

Organ transplantation in Poland

M. Durlik,

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

489 0